RXi Pharma Collaborating with NAAF and Dr. Maria Hordinsky
RXi Pharmaceuticals has entered into a collaboration with Dr. Maria Hordinsky of the University of Minnesota and the National Alopecia Areata Foundation (NAAF) for the study of Samcyprone™ in the treatment of alopecia areata, with the aim to optimize the treatment regimen of diphencyprone is this dermatological disorder, and to better understand the mechanism of action of the drug in this disease. This collaboration could lead to novel targets for development of potent RNAi compounds against this disease based on our sd-rxRNA® platform. Maria K. Hordinsky, M.D. is Professor and Chair of the Department of Dermatology at the University of Minnesota, Twin Cities campus. Dr. Hordinsky is the current president of the Association of Professors of Dermatology, Chair of the Clinical Research Advisory Council of the National Alopecia Areata Foundation and is Secretary/Treasurer of the North American Hair Research Society.